Fujifilm’s Holly Springs facility is one of North America's largest end-to-end cell culture biopharmaceutical manufacturing facilities and represents a key node in the company’s growing global manufacturing network. The post Fujifilm Selected with Six Others in FDA PreCheck Pilot Manufacturing Program appeared first on GEN – Genetic Engineering and Biotechnology News.
You may also like
EC approves Erbitux combination for first‑line...
FDA approves Leqembi Iqlik subcutaneous initiation...
AstraZeneca agrees on $1.5bn deal with Dizal...
Cherry appoints Peter Henshaw as new Managing Director
FDA Issues Proposal to Streamline Registration for...
Cellares and Sonoma Biotherapeutics Agree to Automate...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.